Pillai, Goonaseelan http://orcid.org/0000-0002-5658-3837
Chibale, Kelly
Constable, Edwin C.
Keller, Akiko N.
Gutierrez, Marcelo M.
Mirza, Fareed
Sengstag, Christian
Masimirembwa, Collen
Denti, Paolo
Maartens, Gary
Ramsay, Michèle
Ogutu, Bernhards
Makonnen, Eyasu
Gordon, Richard
Ferreira, Carlos Gil
Goldbaum, Fernando Alberto
Degrave, Wim M. S.
Spector, Jonathan
Tadmor, Brigitta
Kaiser, Hedwig J.
Funding for this research was provided by:
Novartis
Universität Basel
Article History
Received: 16 June 2017
Accepted: 21 September 2018
First Online: 10 October 2018
Ethics approval and consent to participate
: This report was categorized as a “quality assurance and practice experience report”, and a specific ethics committee approval was deemed unnecessary according to Swiss national guidelines (ExternalRef removed see pages 24–25). The report includes data from a survey of NGS fellows, for which all respondents confirmed their written consent to participate in the evaluation of the program. Respondents who are cited in Table InternalRef removed and who are identifiable via their published literature reviewed the text and provided additional written permission and specific approval for how their experience in the program has been described in this manuscript. The program that is described in this report was compliant with Swiss law and ethical, legal and financial guidelines of the University of Basel and Novartis.
: All respondents confirmed their written consent to participate in the evaluation of the program. Respondents who are cited in Table InternalRef removed and who are identifiable via their published literature reviewed and edited the text describing their work, and provided their written approval and specific written permission for how their experience in the program has been described in this manuscript.
: GP, AK, MG, FM, JS, BT were employees of Novartis at the time of this study. GP is an employee of CP+ Associates GmbH, a consulting firm focused on scientific capability development in low- and middle-income countries.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.